1. Dear Drugs-Forum readers: We are a small non-profit that runs one of the most read drug information & addiction help websites in the world. We serve over 4 million readers per month, and have costs like all popular websites: servers, hosting, licenses and software. To protect our independence we do not run ads. We take no government funds. We run on donations which average $25. If everyone reading this would donate $5 then this fund raiser would be done in an hour. If Drugs-Forum is useful to you, take one minute to keep it online another year by donating whatever you can today. Donations are currently not sufficient to pay our bills and keep the site up. Your help is most welcome. Thank you.
    Dismiss Notice


Discussion in 'Drug Articles' started by chibi curmudgeon, Feb 27, 2012.

  1. chibi curmudgeon

    chibi curmudgeon Gold Finger

    Reputation Points:
    Nov 26, 2008
    Fluoxetine HCl (Prozac, Sarafem) is probably the most well-known antidepressant and the archetypal selective serotonin reuptake inhibitor (SSRI). It is used for the pharmacological treatment of several mental disorders, most notably depression and anxiety, and sometimes neuropathy.

    [h="1"]Introduction to [VAR]PAGENAME[/VAR][/h]
    [imgr=white]http://www.drugs-forum.com/forum/attachment.php?attachmentid=21397&d=1310507672[/imgr]Fluoxetine is a highly selective inhibitor of the serotonin transporter (SERT,) preventing serotonin in the synapse from being taken back into the presynaptic neuron. This increases the amount of serotonin available to postsynaptic receptors. Fluoxetine is a relatively safe antidepressant with few serious side effects, although combinations with other serotonergic drugs can result in possibly fatal serotonin syndrome. Fluoxetine has by far the longest half-life of all SSRIs. Fluoxetine is a first-line treatment for major depressive disorder and is less likely to cause a discontinuation syndrome than any other SSRI.

    [h="1"]Using [VAR]PAGENAME[/VAR][/h]

    [h="2"]Ways of Administration[/h]

    Fluoxetine is available in immediate-release capsules and tablets in dosages of 10, 20, and 40 mg, a delayed-release capsule containing 90 mg fluoxetine in enteric-coated pellets (Prozac Weekly,) and an oral solution containing 20 mg fluoxetine/5 ml.[FOOTNOTE]Prozac Prescribing Information (2006) Eli Lilly and Company. In Physician's Desk Reference, 61st ed. Thomson PDR, Montvale, NJ.[/FOOTNOTE]

    [h="2"]Effects of [VAR]PAGENAME[/VAR] [/h]

    As with other antidepressants, fluoxetine may take 2 or more weeks to produce a noticeable effect; single doses have minimal utility. Fluoxetine's psychoactive effects are usually subtle; euphoria and CNS stimulation or depression are estimated to occur in 1/100-1/1000 patients and thus the drug is considered to have minimal recreational potential. Emotional blunting, an inability to feel extreme emotions of any kind, is often reported.

    There is controversy regarding the efficacy of fluoxetine and other SSRIs; in some clinical trials there is little to no statistically significant difference between the effects of fluoxetine and a placebo.

    [h="2"]Combinations with [VAR]PAGENAME[/VAR][/h]

    Fluoxetine is commercially available in combination with the 2nd-generation antipsychotic olanzapine, as Symbyax, for depressive episodes of bipolar disorder. Symbyax contains either 6 or 12 mg olanzapine with either 25 or 50 mg fluoxetine.

    [h="2"]Different Uses for [VAR]PAGENAME[/VAR][/h]

    In the U.S., fluoxetine is approved for major depressive disorder, obsessive-compulsive disorder, bulimia nervosa, and panic disorder alone and with agoraphobia, and premenstrual dysphoric disorder, and sometimes prescribed off-label for selective mutism, post-traumatic stress disorder (PTSD), social anxiety disorder, chronic neuropathic pain, fibromyalgia, and Raynaud's phenomenon.

    [h="1"]Pharmacology of [VAR]PAGENAME[/VAR][/h]

    LD[SUB]50[/SUB] (mg/kg) as hydrochloride :
    Mice : 248 (orally)
    Rat : 452 (orally)

    Fluoxetine inhibits serotonin reuptake almost exclusively, having no clinically appreciable effect on adrenergic, dopaminergic, muscarinic, or histaminergic receptors.

    It is available as a racemic mixture of R and S enantiomers, which are mostly pharmacologically equivalent. Fluoxetine in plasma is approximately 94.5% bound to proteins, including albumin and alpha-1-glycoprotein.

    Fluoxetine is effectively absorbed thorugh oral administration, with bioavailability of at least 60-80%. Time to peak plasma concentrations is between 4-8 hours following oral administration of normal therapeutic preparations and doses.

    Fluoxetine is a substrate and inhibitor of cytochrome P450 2D6, and inhibits several other isoforms as well. It is extensively metabolized by the liver to norfluoxetine and several inactive metabolites. S-norfluoxetine is also a potent SSRI.

    The half-life of fluoxetine ranges from 1 to 6 days, depending on acute or chronic administration, and norfluoxetine's may be as long as 16 days. Hence weekly dosing is feasible with fluoxetine, missed daily doses are rarely problematic, and SSRI discontinuation syndrome is unlikely.

    [h="1"]Chemistry of [VAR]PAGENAME[/VAR][/h]
    Column 1 Column 2
    0 Systematic(IUPAC) name: N-Methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]-1-propanamine
    1 Synonyms: Prozac, Sarafem, Fontex,
    2 Molecular Formula: C[SUB]17[/SUB]H[SUB]18[/SUB]F[SUB]3[/SUB]NO
    3 Molar mass: 309.33 g/mol.
    4 CAS Registry Number: 54910-89-3
    5 Melting Point: 179-182 ℃
    6 Boiling Point: 395 ℃
    7 Flash Point: 192.757 °C
    8 Solubility: Sparingly soluble in Water and in Dichloromethane (DCM); Freely soluble in Ethanol and in methanol; practically insoluble in Ether

    Column 1 Column 2
    0 Title compound: [VAR]PAGENAME[/VAR]
    1 Systematic (IUPAC) name: N-Methyl-[gamma]-[4-(trifluoromethyl)phenoxy]benzenepropanamine
    2 Synonyms: (±)-N-methyl-3-phenyl-3-[([alpha],[alpha],[alpha]-trifluoro-p-tolyl)oxy]propylamine, dl-N-methyl-3-(p-trifluoromethylphenoxy)-3-phenylpropylamine; LY-110140, Adofen, Fluctin, Fluneurin, Fluoxeren, Fluox-Puren, Flusol, Fluxet, Fontex, Foxetin, Lovan, Prozac, Reconcile, Sarafem (hydrochloride)
    3 Molecular Formula: C[sub]17[/sub]H[sub]18[/sub]F[SUB]3[/SUB]NO
    4 Molar mass: 309.33 g/mol, 345.79 g/mol (hydrochloride)
    5 CAS Registry Number: 54910-89-3, 59333-67-4 (hydrochloride)
    6 Melting Point: 158.4-158.9°C (hydrochloride)
    7 Boiling Point: no data
    8 Flash Point: no data
    9 Solubility: Hydrochloride (mg/mL) : methanol, ethanol > 100; acetone, acetonitrile, chloroform 33-100; dichloromethane 5-10; ethyl acetate 2-2.5; toluene, cyclohexane, hexane 0.5-0.67; maximum solubility in water 14; practically insoluble in ether
    10 Additionnal data: none
    11 Notes: hydrochloride aspect : white to off white crystalline powder. There is mention of an oxalate salt (mp 179-182°C).
    [h="1"]The Dangers of [VAR]PAGENAME[/VAR][/h]
    [h="2"]Physical Health Risks[/h]
    [h="3"]Physical Problem 1[/h]

    [h="3"]Physical Problem 2[/h]

    Fluoxetine has an advantage over tricyclic antidepressants and monoamine oxidase inhibitors in that overdoses are rarely fatal. Seizures, coma, and cardiac arrythmias may result, but most patients survive overdoses without sequelae.
    [h="2"]Reported Deaths[/h]

    [h="2"]Mental Health Risks[/h]
    Fluoxetine's prescribing information includes a black box warning for suicidality in children and adolescents aged under 25, and caregivers are warned to monitor patients taking fluoxetine for changes in mood and behavior. However, meta-analyses of clinical trials suggest this may not be as much of a problem as such a warning implies. The benefits of treating depression appear to outweigh the risks of no treatment.[FOOTNOTE]Beasley CM Jr, Dornseif BE, Bosomworth JC, Sayler ME, Rampey AH Jr, Heiligenstein JH, Thompson VL, Murphy DJ, Masica DN. Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression. British Medical Journal. 1991 Sep 21;303(6804):685-92.[/FOOTNOTE][FOOTNOTE]Bridge JA, Iyengar S, Salary CB, Barbe RP, Birmaher B, Pincus HA, Ren L, Brent DA. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. Journal of the American Medical Association. 2007 Apr 18; 297(15):1683-96.[/FOOTNOTE]

    [h="3"]Mental Health Risk 1[/h]
    In patients with bipolar disorder, fluoxetine may trigger mania, but has been successfully used as monotherapy in clinical trials.
    [h="3"]Mental Health Risk 2[/h]

    [h="2"]Side Effects[/h]
    The most common adverse events associated with fluoxetine include nausea/vomiting and diarrhea, due to the effects of 5HT3 receptors in the chemoreceptor trigger zone. Fluoxetine may also cause dry mouth, appetite loss, insomnia or somnolence, bleeding due to inhibited platelet activity, and various sexual problems including lowered libido, difficulty orgasming, and erectile dysfunction.
    [h="3"]Physical Addiction[/h]
    [h="3"]Mental Addiction[/h]

    [h="1"]Producing/Growing [VAR]PAGENAME[/VAR][/h]

    [h="1"]Forms of [VAR]PAGENAME[/VAR][/h]

    [h="1"]Legal Status of [VAR]PAGENAME[/VAR][/h]
    [h="2"]United Nations[/h]
    Fluoxetine is prescription-only but not a controlled substance.

    [h="2"]Other Countries[/h]

    [h="1"]History of [VAR]PAGENAME[/VAR][/h]
    Fluoxetine was developed by Eli Lilly in the 1970s and was approved by the FDA in 1987.

    [h="1"]More [VAR]PAGENAME[/VAR] Sections[/h]


    [h="1"]The Latest [VAR]PAGENAME[/VAR] Threads[/h]



    [1]Merck Index, fifteenth edition (2013)
  2. C.D.rose

    C.D.rose Donating

    Reputation Points:
    Jan 14, 2006
    First! ;)

    I added a few more words to the article header, and I edited the introduction section. In that section I added a reference to serotonin syndrome and I removed the part that said that, due to its long half-life, fluoxetine can be taken weekly. I see that there is a sort of depot formulation of fluoxetine (Prozac Weekly), but if a reference to once-weekly use is made, it should be by pointing out that this can only be done with Prozac Weekly. I don't want anyone to read this article and think "hey, I'll just add up seven daily doses and take them all at once." This would probably be less dangerous than with some other drugs, but it would be somewhat dangerous nonetheless.

    The image of the fluoxetine molecule could maybe be placed at the top of the article, but I don't want to mess with that just now.

  3. chibi curmudgeon

    chibi curmudgeon Gold Finger

    Reputation Points:
    Nov 26, 2008
    Ah, good call. I'm bad at writing introductions.
  4. sassyspy

    sassyspy Palladium Member

    Reputation Points:
    Mar 24, 2011
    Am I wrong in thinking the "combinations with" section is meant to contain info on the potential reactions when combined with other drugs?

    No criticism meant, but happened to be looking for examples of prozac when mixed with other drugs, and thought that was the section it was meant to be in.?
    If not, I will be needing to go back and edit my additions!:s

    Thanks much!:)
  5. chibi curmudgeon

    chibi curmudgeon Gold Finger

    Reputation Points:
    Nov 26, 2008
    No, you're right, but I figured I'd start with the commercially available combination. I might also mention the other psych meds with which it's frequently combined. Contraindications should go there, too. I just happened to lose access to my favorite online resource right before I decided to start the wiki because the universe hates me.
  6. sassyspy

    sassyspy Palladium Member

    Reputation Points:
    Mar 24, 2011
    :vibes:not the whole universe, lovey! But I know how you feel!

    Well, thanks for saving my day... :) hate going back and editing my edits!
  7. Calliope

    Calliope κυνική

    Reputation Points:
    Feb 18, 2012
    adding antidepressant category, updating parts of template so rearranged some of the content, did chemistry table, bit to introduction section. uploaded two ref articles and inked them.

    I am nit sure with these particular wikis -- the pharmaceutics, antidepressants whether one id supposed to keep every section form the template in, it seems a bit odd to have, for example, producing/growing as a section. I've left all in for now, but will remove if this is the wat to go.